Company Innovus Pharmaceuticals Inc OTC Bulletin Board
Equities
US45778V1061
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 31/05/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,204,401 | 2,483,540 ( 77.50 %) | 0 | 77.50 % |
Company contact information
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.com![address Innovus Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/9598487.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- Stock
- Stock
- Company Innovus Pharmaceuticals Inc